Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly 2022-01-24 23:35
Optina announces a US$2.1M investment from the Diagnostics Accelerator at the Alzheimer's Drug Discovery Foundation (ADDF) 2022-01-24 22:15
MGI's New MGISP-Smart 8 Automated Sample Preparation System Makes International Debut at MEDLAB Middle East 2022-01-24 19:30
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Hong Kong Market for the Treatment of Adults With Locally Advanced Or Metastatic Cholangiocarcinoma With A FGFR2 Fusion Or Rearrangement That Have Progressed After At Least One Prior Line Of Systemic Therapy 2022-01-24 15:22
Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers 2022-01-24 13:10
New York Medical Group Publishes Research on Tech Neck 2022-01-24 12:39
Infinitus releases 2021 Corporate Social Responsibility Report 2022-01-24 09:00
Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma 2022-01-23 18:35
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022 2022-01-22 08:00
Swiss Pharma Company - IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat) 2022-01-22 04:24
Ashraya Foundation Signs 60 Crore INR Agreement with Edufront Technologies 2022-01-21 18:30
Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd. 2022-01-21 11:12
ESTA Lunar New Year with UltraBactech, proven to target and kill 99.999% of the SARS-CoV-2 virus, presents the new Spring collection design & gift sets 2022-01-21 10:30
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment 2022-01-21 05:30
Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022 2022-01-20 23:05
Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing 2022-01-20 21:15
Victor Papamoniodis Joins Medison Pharma as VP International Markets 2022-01-20 20:35
Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy 2022-01-20 19:00
Successful Groundbreaking Ceremony for GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China 2022-01-20 16:44
Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI 2022-01-20 16:00
1 236 237 238 239 240 738